Hematology Clinical Science Director — Strategy & Leadership

Scorpion Therapeutics; New Jersey; On-site; USD 190,000 - 290,000; Full time

Job summary

Scorpion Therapeutics seeks a Senior Director, Clinical Science – Hematology to lead strategic Clinical Science across hematology programs and assets. You will align disease area strategy with portfolio goals, partnering with asset leads and program development teams to shape study design, endpoints, and biomarker strategies.

The role requires deep hematologic cancer expertise, senior scientific judgment, and proven leadership in oncology clinical development, with responsibility for

Qualifications

• Advanced degree required with extensive hematology/oncology drug development experience.
• Proven ability to lead clinical science across multiple studies and assets.
• Strong cross-functional collaboration and executive communication skills.

Responsibilities

• Provide strategic Clinical Science leadership across hematology programs and assets.
• Contribute to disease area strategy and portfolio risk assessment.
• Partner with Section Heads, Asset Leads, and Program Development Team Leads for alignment.
• Apply hematologic cancer expertise to study planning, endpoints, and data interpretation.
• Standardize Clinical Science approaches across hematology and ensure governance compliance.
• Provide senior scientific guidance and frame issues for cross-functional discussions.
• Lead protocol development, study design, and biomarker strategy discussions.
• Present scientific insights in leadership meetings and portfolio reviews.
• Provide people leadership: coach and mentor Directors/Scientists.

Skills

Clinical Development Leadership

Hematologic oncology

Cross-functional collaboration

Executive communication

Education

PhD or PharmD in life sciences

Master’s in life sciences

Job description

Scorpion Therapeutics seeks a Senior Director, Clinical Science – Hematology to lead strategic Clinical Science across hematology programs and assets. You will align disease area strategy with portfolio goals, partnering with asset leads and program development teams to shape study design, endpoints, and biomarker strategies.

The role requires deep hematologic cancer expertise, senior scientific judgment, and proven leadership in oncology clinical development, with responsibility for